Intrinsic Value

The intrinsic value of Sectra AB (61L0) under the Base Case is 16.83 EUR per share. Compared with the current market price of 29.98 EUR, the stock appears Overvalued by 44% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

61L0 Intrinsic Value
€16.83
Overvaluation 44%
Intrinsic Value
Price €29.98

61L0 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor 61L0
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €13.47
Get notified when the price drops into your buy zone
Current Price €29.98
Intrinsic Value €16.83
Margin of Safety 20% €13.47
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 61L0

Fundamental Analysis

What Sectra AB Does

Health Care

Sectra makes software that helps hospitals and other organizations handle sensitive information. In healthcare, it sells imaging and workflow systems for radiology, orthopedics, pathology, and enterprise image sharing, letting doctors view, store, and analyze medical images in one place. It also sells secure communication tools for governments, defense agencies, and other organizations that need strong protection for classified or confidential data.

Headquarters
Sweden SE
Employees
1 001
IPO date
Mar 3, 1999
Read the full company overview
View Company Overview

Sectra has no economic moat

No Moat Narrow Wide

Sectra AB lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Sectra AB

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 61L0 stock?

The intrinsic value for Sectra AB (61L0) under the Base Case is 16.83 EUR.

Is 61L0 stock undervalued or overvalued?

Compared with the current market price of 29.98 EUR, the stock appears Overvalued by 44% .

Back to Top